Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

33.08 USD +0.11 (+0.33%)
Official Closing Price Updated: 7:42 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bausch Health Companies Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®
From GlobeNewswire News Releases
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $100 million through the redemption of outstanding senior notes, using cash... 
From PR Newswire
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Australia's Therapeutic Goods... 
From PR Newswire
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the launch of Bausch + Lomb INFUSE™ silicone hydrogel (SiHy) daily... 
From PR Newswire
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Health Canada for the sale of... 
From PR Newswire
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
From GlobeNewswire News Releases
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results
From PR Newswire
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that it intends to spin off its leading eye health business into an independent publicly traded entity... 
From PR Newswire
Bausch Health Resolves Canadian Securities Class Action
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), today announced that the parties in the Canadian securities class action (Cattuci et al. v. Valeant Pharmaceuticals... 
From PR Newswire
Bausch Health Resolves Legacy SEC Investigation
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), f/k/a Valeant Pharmaceuticals International, Inc. ("Valeant"), today announced the successful resolution of the legacy... 
From PR Newswire
Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the recipients of... 
From PR Newswire
Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will release its second-quarter 2020 financial results on Thursday, Aug. 6, 2020. Bausch Health will host a conference... 
From PR Newswire
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Generic Product Collaborations between the Companies Now Cover Ten Products 
From GlobeNewswire News Releases
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world, today announced that... 
From PR Newswire
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that BAUSCH + LOMB ULTRA® monthly silicone hydrogel contact lenses... 
From PR Newswire
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Paul S. Herendeen, executive vice president and chief financial officer, Arthur J. Shannon, senior vice president and head of Investor... 
From PR Newswire
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients
$10,000 Scholarships Awarded to 10 Students Affected by GI Diseases 
From PR Newswire
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received 510(k) clearance from the U.S. Food and Drug... 
From PR Newswire
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses
LuxSmart and LuxGood Feature Pure Refractive Optics (PRO) Technology 
From PR Newswire
Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and... 
From PR Newswire
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously announced offering of $1,500,000,000 aggregate principal... 
From PR Newswire
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of $1,250,000,000 aggregate principal amount of new senior notes due... 
From PR Newswire
Bausch Health Companies Inc. Announces First-Quarter 2020 Results
From PR Newswire
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), which is one of the largest specialty... 
From PR Newswire
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and... 
From PR Newswire
Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting
14 Abstracts Demonstrate Company's Commitment to Leadership in Gastroenterology 
From PR Newswire
Bausch Health Announces 2020 Annual Meeting Of Shareholder Results
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the election of the eleven directors nominated at its 2020 annual meeting of shareholders held on April... 
From PR Newswire
FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the U.S. Food and... 
From PR Newswire
Bausch Health Issues Form 8-K For 2020 Annual Meeting Of Shareholders Presentation
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the Company is providing a presentation (the "2020 Annual Meeting of Shareholders") on its business... 
From PR Newswire
Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will release its first-quarter 2020 financial results on Thursday, May 7, 2020. Bausch Health will host a conference call... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.